首页 >
法规速递
-
国家药监局关于莲芝消炎软胶囊和肾骨片转换为非处方药的公告（2025年第84号） -2025/9/12
2025-09-12查看详情 > -
Document: Minutes of the CVMP meeting 9-10 September 2025-2025/10/17
2025-10-17查看详情 > -
国家药监局综合司关于印发《药用辅料附录检查指导原则》《药包材附录检查指导原则》的通知-2025/11/21
2025-11-24查看详情 > -
Study of Sex Differences in the Clinical Evaluation of Medical Products-2025/12/15
2025-12-16查看详情 > -
Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders-2026/1/28
2026-01-29查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第一百零二批）及调出参比制剂目录品种清单（第四批）的通告（2026年第7号）-2026/3/9
2026-03-10查看详情 > -
Document: CHMP PROM minutes for the meeting on 10 June 2025-2026/4/7
2026-04-08查看详情 > -
中药新药用于慢性胃炎的临床疗效评价技术指导原则（试行）-2022/12/21
2022-12-22查看详情 > -
关于公开征求《抗肿瘤药物说明书安全性信息撰写技术指导原则（征求意见稿）》意见的通知-2023/6/30
2023-06-30查看详情 > -
Development and manufacture of human medicinal products specifically designed for phage therapy - Scientific guideline-2023/12/22
2024-01-03查看详情 >
